Skip to main content

Aspergillosis clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Olorofim Aspergillus Infection Study

    open to eligible people ages 18 years and up

    The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).

    San Francisco, California and other locations

Last updated: